Parametric Portfolio Associates’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $49K | Sell |
504
-751
| -60% | -$73K | ﹤0.01% | 3633 |
|
2021
Q4 | $205K | Sell |
1,255
-3,299
| -72% | -$539K | ﹤0.01% | 3414 |
|
2021
Q3 | $1.24M | Buy |
4,554
+2,830
| +164% | +$772K | ﹤0.01% | 2695 |
|
2021
Q2 | $683K | Buy |
1,724
+873
| +103% | +$346K | ﹤0.01% | 2944 |
|
2021
Q1 | $460K | Buy |
851
+357
| +72% | +$193K | ﹤0.01% | 3539 |
|
2020
Q4 | $187K | Buy |
494
+230
| +87% | +$87.1K | ﹤0.01% | 3797 |
|
2020
Q3 | $100K | Sell |
264
-38
| -13% | -$14.4K | ﹤0.01% | 3796 |
|
2020
Q2 | $148K | Sell |
302
-47
| -13% | -$23K | ﹤0.01% | 3706 |
|
2020
Q1 | $128K | Buy |
349
+48
| +16% | +$17.6K | ﹤0.01% | 3673 |
|
2019
Q4 | $213K | Buy |
301
+52
| +21% | +$36.8K | ﹤0.01% | 3720 |
|
2019
Q3 | $160K | Buy |
249
+62
| +33% | +$39.8K | ﹤0.01% | 3759 |
|
2019
Q2 | $163K | Buy |
187
+18
| +11% | +$15.7K | ﹤0.01% | 3777 |
|
2019
Q1 | $97K | Sell |
169
-37
| -18% | -$21.2K | ﹤0.01% | 3822 |
|
2018
Q4 | $58K | Buy |
206
+65
| +46% | +$18.3K | ﹤0.01% | 3838 |
|
2018
Q3 | $68K | Sell |
141
-239
| -63% | -$115K | ﹤0.01% | 3888 |
|
2018
Q2 | $172K | Buy |
380
+52
| +16% | +$23.5K | ﹤0.01% | 3725 |
|
2018
Q1 | $193K | Sell |
328
-1,003
| -75% | -$590K | ﹤0.01% | 3769 |
|
2017
Q4 | $827K | Buy |
1,331
+761
| +134% | +$473K | ﹤0.01% | 3109 |
|
2017
Q3 | $525K | Sell |
570
-1
| -0.2% | -$921 | ﹤0.01% | 3396 |
|
2017
Q2 | $533K | Buy |
571
+31
| +6% | +$28.9K | ﹤0.01% | 3334 |
|
2017
Q1 | $514K | Buy |
540
+413
| +325% | +$393K | ﹤0.01% | 3190 |
|
2016
Q4 | $102K | Buy |
127
+3
| +2% | +$2.41K | ﹤0.01% | 3703 |
|
2016
Q3 | $105K | Sell |
124
-529
| -81% | -$448K | ﹤0.01% | 3672 |
|
2016
Q2 | $538K | Buy |
653
+499
| +324% | +$411K | ﹤0.01% | 3147 |
|
2016
Q1 | $171K | Buy |
154
+13
| +9% | +$14.4K | ﹤0.01% | 3777 |
|
2015
Q4 | $176K | Sell |
141
-19
| -12% | -$23.7K | ﹤0.01% | 3760 |
|
2015
Q3 | $217K | Buy |
160
+17
| +12% | +$23.1K | ﹤0.01% | 3063 |
|
2015
Q2 | $257K | Sell |
143
-292
| -67% | -$525K | ﹤0.01% | 3651 |
|
2015
Q1 | $703K | Sell |
435
-121
| -22% | -$196K | ﹤0.01% | 3048 |
|
2014
Q4 | $423K | Buy |
556
+2
| +0.4% | +$1.52K | ﹤0.01% | 3358 |
|
2014
Q3 | $219K | Sell |
554
-27
| -5% | -$10.7K | ﹤0.01% | 3585 |
|
2014
Q2 | $352K | Sell |
581
-602
| -51% | -$365K | ﹤0.01% | 3425 |
|
2014
Q1 | $813K | Buy |
1,183
+321
| +37% | +$221K | ﹤0.01% | 2834 |
|
2013
Q4 | $561K | Buy |
862
+356
| +70% | +$232K | ﹤0.01% | 3089 |
|
2013
Q3 | $299K | Buy |
506
+238
| +89% | +$141K | ﹤0.01% | 3396 |
|
2013
Q2 | $85K | Buy |
+268
| New | +$85K | ﹤0.01% | 3609 |
|